Cannabix Technologies Inc (BLOZF)

[medchem]

Yes there is. Shoot them an email. Or just read the following:

"The developmental testing of the latest FAIMS device is now completed and we are about to begin the performance testing of the V2 prototype which will be completed by the end of the month barring any technical issues."

As the quote states, they have finished testing version 1 of the FAIMS device, which is a prototype. Now they are moving on to version 2, which is also a prototype by definition.

Importantly, if you review their website, you will note that there has not been a news release regarding FAIMS. Detection of breath biomarkers of disease is inherently much easier than detecting fleeting THC molecules in a 2 hour time window (abundance is key). So if Cannabix is moving to trial testing, you know who else will be as well.

Trial testing here we come.